Evaluation of fluorescent compound interference in 4 fluorescence polarization assays: 2 kinases, 1 protease, and 1 phosphatase.
With the increasing use of fluorescence-based assays in high-throughput screening (HTS), the possibility of interference by fluorescent compounds needs to be considered. To investigate compound interference, a well-defined sample set of biologically active compounds, LOPAC, was evaluated using 4 fluorescein-based fluorescence polarization (FP) assays. Two kinase assays, a protease assay, and a phosphatase assay were studied. Fluorescent compound interference and light scattering were observed in both mixture- and single-compound testing under certain circumstances. In the kinase assays, which used low levels (1-3 nM) of fluorophore, an increase in total fluorescence, an abnormal decrease in mP readings, and negative inhibition values were attributed to compound fluorescence. Light scattering was observed by an increase in total fluorescence and minimal reduction in mP, leading to false positives. The protease and phosphatase assays, which used a higher concentration of fluorophore (20-1200 nM) than the kinase assays, showed minimal interference from fluorescent compounds, demonstrating that an increase in the concentration of the fluorophore minimized potential fluorescent compound interference. The data also suggests that mixtures containing fluorescent compounds can result in either false negatives that can mask a potential "hit" or false positives, depending on the assay format. Cy dyes (e.g., Cy3B and Cy5 ) excite and emit further into the red region than fluorescein and, when used in place of fluorescein in kinase 1, eliminate fluorescence interference and light scattering by LOPAC compounds. This work demonstrates that fluorescent compound and light scattering interferences can be overcome by increasing the fluorophore concentration in an assay or by using longer wavelength dyes.
Turek-Etienne
Tammy C
TC
New Lead Discovery, Schering-Plough Research Institute K15 4/4800 B421C, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA. tammy.turek-etienne@spcorp.com
Small
Eliza C
EC
Soh
Sharon C
SC
Xin
Tianpei A
TA
Gaitonde
Priti V
PV
Barrabee
Ellen B
EB
Hart
Richard F
RF
Bryant
Robert W
RW
D001681:Biological Assay / Q000379:methods*; D010450:Endopeptidases / Q000378:metabolism*; D019793:Fluorescein / Q000378:metabolism; D005454:Fluorescence Polarization / Q000379:methods*; D005456:Fluorescent Dyes / Q000737:chemistry / Q000378:metabolism*; D015394:Molecular Structure; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism*; D010770:Phosphotransferases / Q000378:metabolism*
D005456:Fluorescent Dyes; D010770:Phosphotransferases; D010744:Phosphoric Monoester Hydrolases; D010450:Endopeptidases; D019793:Fluorescein